First I haven't always got thing right, but I am sorry to say this has a look of things not quite right about it.
So is there some bad news on the way, who knows but the first patient in the extension trial was dosed nearly 6 months ago and the trial document I believe says that the patients would be assessed ALS function table from Baseline to 4 weeks, why not update on patients
Latest MND Webinar information on Monepantel, page-11
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
0.015(6.98%) |
Mkt cap ! $111.9M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 23.0¢ | 21.5¢ | $475.3K | 2.128M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 93524 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 71004 | 2 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| PAA (ASX) Chart |